Emergency Cancer Care最新文献

英文中文

Neurosurgical emergencies in spinal tumors: pathophysiology and clinical management 脊柱肿瘤的神经外科急诊：病理生理学和临床管理

Emergency Cancer Care

Pub Date : 2024-02-16 DOI: 10.1186/s44201-024-00024-5

Christina Abi Faraj, Rita I. Snyder, Claudio E. Tatsui, Ian E. McCutcheon

引用次数: 0

Emergency Cancer Care

Pub Date : 2024-01-29 DOI: 10.1186/s44201-023-00023-y

C. Reyes-Gibby, J. Caterino, Christopher J. Coyne, Demetrios N. Kyriacou, A. Qdaisat, Jennifer McQuade, Dwight H. Owen, J. Bischof, Sanjay Shete, Sai-Ching J. Yeung

引用次数: 0

Variables associated with admission rates among cancer patients presenting to emergency departments: a CONCERN group study 与急诊科癌症患者入院率相关的变量：CONCERN 小组研究

Emergency Cancer Care

Pub Date : 2023-11-30 DOI: 10.1186/s44201-023-00022-z

J. Rico, J. Caterino, Julie A. Stephens, B. Abar, David Adler, A. Bastani, Steven L. Bernstein, J. Bischof, Christopher J. Coyne, C. Grudzen, Daniel J. Henning, Matthew F Hudson, A. Klotz, Gary H. Lyman, Troy E. Madsen, Cielito C. Reyes, Richard J. Ryan, Nathan I. Shapiro, R. Swor, Charles R. Thomas, A. Venkat, Jason Wilson, S.-C. Jim Yeung, Sule Yilmaz, Christopher W. Baugh

引用次数: 0

Emergency department visits among patients receiving systemic cancer treatment in the ambulatory setting 在门诊环境中接受全身癌症治疗的患者的急诊科访问

Emergency Cancer Care

Pub Date : 2023-11-03 DOI: 10.1186/s44201-023-00021-0

Naheel Said, Wedad Awad, Zahieh Abualoush, Lama Nazer

Abstract Background Most patients receive systemic cancer treatment in the ambulatory setting. However, during their treatment journey, patients experience complications that necessitate emergency department (ED) visits. Few studies evaluated the burden of such visits and their characteristics. This study aimed to evaluate the incidence and characteristics of ED visits among adult cancer patients receiving systemic cancer treatment in the ambulatory setting. Methods A retrospective observational study was conducted at a comprehensive cancer center in Jordan. Utilizing the medical records database, we identified all patients treated in the chemotherapy infusion units, between January and December 2021. Patients who received only supportive therapy were excluded. The proportion of patients who required ED visits, their characteristics, types of cancer treatments received, and reasons for ED visits were recorded. Results Over the study period, 4985 patients received 38,803 treatment cycles in the infusion units. Among those, 2773 (55.6%) patients had 10,061 ED visits. Patients who presented to the ED had a mean age of 53.7 ± 13.8 (SD) years and 1763 (63.6%) were females. The most common types of malignancies were breast (39.5%) and gastrointestinal (20%). The most common cancer treatments associated with ED visits were platinum-based (24.8%), immune-mediated/targeted therapy (15.3%), and hormonal (12.3%). The most common admission diagnoses were neuromuscular/skeletal symptoms (34.8%) and gastrointestinal symptoms (20.2%). Conclusions In a large cohort of cancer patients receiving cancer treatment in the ambulatory setting, over half of them required at least one ED visit. Most visits were for neuromuscular/skeletal and gastrointestinal symptoms. Future studies should identify measures to reduce ED visits to enhance the patients’ quality of life and outcomes and optimize resources.

背景:大多数患者在门诊接受全身癌症治疗。然而，在他们的治疗过程中，患者会遇到并发症，需要急诊科(ED)访问。很少有研究评估这种访问的负担及其特征。本研究旨在评估在门诊接受全身癌症治疗的成年癌症患者急诊科就诊的发生率和特点。方法在约旦某综合性癌症中心进行回顾性观察研究。利用医疗记录数据库，我们确定了2021年1月至12月期间在化疗输液单元接受治疗的所有患者。仅接受支持性治疗的患者被排除在外。需要急诊科就诊的患者比例、他们的特征、接受的癌症治疗类型以及急诊科就诊的原因都被记录下来。结果在研究期间，4985例患者在输液单元接受了38803个治疗周期。其中，2773例(55.6%)患者就诊10061次。到急诊科就诊的患者平均年龄为53.7±13.8 (SD)岁，其中女性为1763(63.6%)。最常见的恶性肿瘤类型是乳腺(39.5%)和胃肠道(20%)。与ED就诊相关的最常见的癌症治疗是铂类(24.8%)、免疫介导/靶向治疗(15.3%)和激素治疗(12.3%)。最常见的入院诊断为神经肌肉/骨骼症状(34.8%)和胃肠道症状(20.2%)。结论:在门诊接受癌症治疗的大量癌症患者中，超过一半的患者至少需要一次急诊科就诊。大多数就诊是由于神经肌肉/骨骼和胃肠道症状。未来的研究应确定减少急诊科就诊的措施，以提高患者的生活质量和预后，并优化资源。

{"title":"Emergency department visits among patients receiving systemic cancer treatment in the ambulatory setting","authors":"Naheel Said, Wedad Awad, Zahieh Abualoush, Lama Nazer","doi":"10.1186/s44201-023-00021-0","DOIUrl":"https://doi.org/10.1186/s44201-023-00021-0","url":null,"abstract":"Abstract Background Most patients receive systemic cancer treatment in the ambulatory setting. However, during their treatment journey, patients experience complications that necessitate emergency department (ED) visits. Few studies evaluated the burden of such visits and their characteristics. This study aimed to evaluate the incidence and characteristics of ED visits among adult cancer patients receiving systemic cancer treatment in the ambulatory setting. Methods A retrospective observational study was conducted at a comprehensive cancer center in Jordan. Utilizing the medical records database, we identified all patients treated in the chemotherapy infusion units, between January and December 2021. Patients who received only supportive therapy were excluded. The proportion of patients who required ED visits, their characteristics, types of cancer treatments received, and reasons for ED visits were recorded. Results Over the study period, 4985 patients received 38,803 treatment cycles in the infusion units. Among those, 2773 (55.6%) patients had 10,061 ED visits. Patients who presented to the ED had a mean age of 53.7 ± 13.8 (SD) years and 1763 (63.6%) were females. The most common types of malignancies were breast (39.5%) and gastrointestinal (20%). The most common cancer treatments associated with ED visits were platinum-based (24.8%), immune-mediated/targeted therapy (15.3%), and hormonal (12.3%). The most common admission diagnoses were neuromuscular/skeletal symptoms (34.8%) and gastrointestinal symptoms (20.2%). Conclusions In a large cohort of cancer patients receiving cancer treatment in the ambulatory setting, over half of them required at least one ED visit. Most visits were for neuromuscular/skeletal and gastrointestinal symptoms. Future studies should identify measures to reduce ED visits to enhance the patients’ quality of life and outcomes and optimize resources.","PeriodicalId":91016,"journal":{"name":"Emergency Cancer Care","volume":"56 11","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135819824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cancer patients in the emergency department or intensive care unit: a 20-year bibliometric analysis of research progress and prospects 急诊科或重症监护病房的癌症患者:20年文献计量学研究进展与展望

Emergency Cancer Care

Pub Date : 2023-06-22 DOI: 10.1186/s44201-023-00020-1

Jinge Shen, Qian Xing, Qi Xu, J. Qian

引用次数: 0

Extended-release, long-acting opioid self-management patterns may pose safety risks in ambulatory persons with cancer pain 延长释放、长效阿片类药物自我管理模式可能对癌症疼痛的流动患者造成安全风险

Emergency Cancer Care

Pub Date : 2023-03-13 DOI: 10.1186/s44201-022-00016-3

S. Meghani

引用次数: 0

Understanding the urgent and emergency care navigation work undertaken by people with cancer and their informal caregivers: a conceptually framed scoping review 了解癌症患者及其非正式护理人员开展的紧急和紧急护理导航工作：概念框架范围界定综述

Emergency Cancer Care

Pub Date : 2023-02-28 DOI: 10.1186/s44201-023-00019-8

J. Defty, R. Wagland, A. Richardson

引用次数: 0

Characteristics and clinical outcomes of patients with lung cancer requiring ICU admission: a retrospective analysis based on the MIMIC-III database 需要入住ICU的癌症患者的特征和临床结果：基于MIMIC-III数据库的回顾性分析

Emergency Cancer Care

Pub Date : 2023-01-10 DOI: 10.1186/s44201-022-00017-2

J. Qian, Ruoyan Qin, Liang Hong, Yangyang Shi, Hai-Liang Yuan, Bo Zhang, W. Nie, Yanwen Li, B. Han

引用次数: 1

Lung cancer in the emergency department. 急诊科的肺癌

Emergency Cancer Care

Pub Date : 2023-01-01 Epub Date: 2023-03-06 DOI: 10.1186/s44201-023-00018-9

Jeremy R Walder, Saadia A Faiz, Marcelo Sandoval

Background: Though decreasing in incidence and mortality in the USA, lung cancer remains the deadliest of all cancers. For a significant number of patients, the emergency department (ED) provides the first pivotal step in lung cancer prevention, diagnosis, and management. As screening recommendations and treatments advance, ED providers must stay up-to-date with the latest lung cancer recommendations. The purpose of this review is to identify the many ways that emergency providers may intersect with the disease spectrum of lung cancer and provide an updated array of knowledge regarding detection, management, complications, and interdisciplinary care.

Findings: Lung cancer, encompassing 10-12% of cancer-related emergency department visits and a 66% admission rate, is the most fatal malignancy in both men and women. Most patients presenting to the ED have not seen a primary care provider or undergone screening. Ultimately, half of those with a new lung cancer diagnosis in the ED die within 1 year. Incidental findings on computed tomography are mostly benign, but emergency staff must be aware of the factors that make them high risk. Radiologic presentations range from asymptomatic nodules to diffuse metastatic lesions with predominately pulmonary symptoms, and some may present with extra-thoracic manifestations including neurologic. The short-term prognosis for ED lung cancer patients is worse than that of other malignancies. Screening offers new hope through earlier diagnosis but is underutilized which may be due to racial and socioeconomic disparities. New treatments provide optimism but lead to new complications, some long-term. Multidisciplinary care is essential, and emergency medicine is responsible for the disposition of patients to the appropriate specialists at inpatient and outpatient centers.

Conclusion: ED providers are intimately involved in all aspects of lung cancer care. Risk factor modification and referral for lung cancer screening are opportunities to further enhance patient care. In addition, with the advent of newer cancer therapies, ED providers must stay vigilant and up-to-date with all aspects of lung cancer including disparities, staging, symptoms of disease, prognosis, treatment, and therapy-related complications.

背景：虽然肺癌在美国的发病率和死亡率都在下降，但它仍然是所有癌症中最致命的一种。对于大量患者来说，急诊科（ED）是肺癌预防、诊断和治疗的第一步。随着筛查建议和治疗方法的发展，急诊科医生必须了解最新的肺癌建议。本综述旨在确定急诊科医生与肺癌疾病谱的多种交叉方式，并提供有关检测、管理、并发症和跨学科护理的最新知识：肺癌占癌症相关急诊就诊人数的 10-12%，入院率为 66%，是男性和女性中最致命的恶性肿瘤。大多数来急诊科就诊的患者都没有看过初级保健医生或接受过筛查。最终，在急诊科确诊的新肺癌患者中有一半会在一年内死亡。计算机断层扫描的意外发现大多是良性的，但急诊人员必须意识到使其成为高风险的因素。放射学表现从无症状结节到以肺部症状为主的弥漫性转移病灶不等，有些患者可能伴有包括神经系统在内的胸腔外表现。与其他恶性肿瘤相比，ED 肺癌患者的短期预后较差。筛查为早期诊断带来了新的希望，但由于种族和社会经济方面的差异，筛查未得到充分利用。新的治疗方法带来了希望，但也导致了新的并发症，有些是长期并发症。多学科治疗至关重要，急诊医学负责将患者转至住院和门诊中心的相应专科：结论：急诊科医护人员密切参与肺癌治疗的方方面面。调整风险因素和转诊肺癌筛查是进一步加强患者护理的机会。此外，随着新型癌症疗法的出现，急诊科医生必须保持警惕，了解肺癌各方面的最新情况，包括差异、分期、疾病症状、预后、治疗和与治疗相关的并发症。

{"title":"Lung cancer in the emergency department.","authors":"Jeremy R Walder, Saadia A Faiz, Marcelo Sandoval","doi":"10.1186/s44201-023-00018-9","DOIUrl":"10.1186/s44201-023-00018-9","url":null,"abstract":"Background: Though decreasing in incidence and mortality in the USA, lung cancer remains the deadliest of all cancers. For a significant number of patients, the emergency department (ED) provides the first pivotal step in lung cancer prevention, diagnosis, and management. As screening recommendations and treatments advance, ED providers must stay up-to-date with the latest lung cancer recommendations. The purpose of this review is to identify the many ways that emergency providers may intersect with the disease spectrum of lung cancer and provide an updated array of knowledge regarding detection, management, complications, and interdisciplinary care.Findings: Lung cancer, encompassing 10-12% of cancer-related emergency department visits and a 66% admission rate, is the most fatal malignancy in both men and women. Most patients presenting to the ED have not seen a primary care provider or undergone screening. Ultimately, half of those with a new lung cancer diagnosis in the ED die within 1 year. Incidental findings on computed tomography are mostly benign, but emergency staff must be aware of the factors that make them high risk. Radiologic presentations range from asymptomatic nodules to diffuse metastatic lesions with predominately pulmonary symptoms, and some may present with extra-thoracic manifestations including neurologic. The short-term prognosis for ED lung cancer patients is worse than that of other malignancies. Screening offers new hope through earlier diagnosis but is underutilized which may be due to racial and socioeconomic disparities. New treatments provide optimism but lead to new complications, some long-term. Multidisciplinary care is essential, and emergency medicine is responsible for the disposition of patients to the appropriate specialists at inpatient and outpatient centers.Conclusion: ED providers are intimately involved in all aspects of lung cancer care. Risk factor modification and referral for lung cancer screening are opportunities to further enhance patient care. In addition, with the advent of newer cancer therapies, ED providers must stay vigilant and up-to-date with all aspects of lung cancer including disparities, staging, symptoms of disease, prognosis, treatment, and therapy-related complications.","PeriodicalId":91016,"journal":{"name":"Emergency Cancer Care","volume":" ","pages":"3"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11116267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48431450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Intracranial emergencies in neurosurgical oncology: pathophysiology and clinical management 神经外科肿瘤的颅内急症:病理生理学和临床处理

Emergency Cancer Care

Pub Date : 2022-12-13 DOI: 10.1186/s44201-022-00013-6

C. Faraj, Rita I Snyder, I. McCutcheon

引用次数: 2

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Emergency Cancer Care

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀